Get To Know Dr Dimitrios Lamprou

My name is Dimitrios Lamprou (Ph.D. MBA) and I am the first Chair (and founder) of the Emerging Technologies Focus Group, which established in March 2021, with the aim to bring together scientists interested in the rapidly growing field of Emerging Technologies for Drug Delivery and Medical Implants, and bridging the gap between industry and academia in this exciting and hot field. From, the beginning of my career, and before that as a student, I always had a strong interested in Emerging Technologies and Medical Implants, and finally now with this APS Focus Group, we all have a “home” to bring all these Emerging Technologies under one roof, support each other, share experiences, and together work towards the development of drug delivery systems and medical devices that were not able to be produced a few years ago.

I am currently a Reader in Pharmaceutical Engineering and Programme Director at MSc Industrial Pharmaceutics at the School of Pharmacy in Queen's University Belfast (UK), with an international reputation in Emerging Technologies for Drug Delivery Systems and Medical Devices & Implants. Author of over 100 peer-reviewed publications, have over 250 conference abstracts, and have given over 100 Invited Talks in institutions and conferences across the world. My research and academic leadership have been recognised in a range of awards, including the Royal Pharmaceutical Society Science Award and the Scottish Universities Life Sciences Alliance Leaders Scheme Award.

I am the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS), Chair (Founder) of the Academy of Pharmaceutical Sciences (APS) Emerging Technologies Focus Group, Member of the British Standards Institute (BSI) AMT/8 committee for Additive Manufacturing, Editor for Heliyon (Pharmaceutical Science, Pharmacology and Toxicology Section), Associate Editor at Frontiers in Medical Technology (Nano-Based Drug Delivery Section), Editor for Topical Collection in Pharmaceutics (3D Printing and Bioprinting Applications in Pharmaceutics), Guest Editor for 17 Special Issues in International Refereed Journals and Editorial Board Member for 3 Refereed Journals. I also have a number of important University & School roles, most noticeably in the arena of Equity, Diversity and Inclusion (EDI).

Specialties: 3D Printing, Bioprinting, Biomaterials, Biomedical Engineering, Controlled Drug Delivery, Electrospinning, Emerging Technologies, Microfluidics, Nanomedicines, Pharmaceutics.

For more info please check at www.emergingtechnologieslab.com 

Comments

Post a Comment

Popular posts from this blog

Image
Dear Scientific community! We are happy to let you know that we are starting our blog (which you can find here ) . We want to use this space to allow early career researchers to share their research experience, training, career journey. We are looking to 500 words unique pieces telling a story about your career or any lab experience that relates to our focus group HOT TOPICs 3D Bioprinting applications in drug discovery & development. 3D Printing Manufacturing of drug delivery systems, medical devices, and implants.  Manufacturing of Nanomedicines by microfluidics. Microfluidics for drug discovery and development. BioMEMS devices as biosensors, drug delivery systems and injectable devices. Artificial intelligence (AI) and machine learning. In silico modelling. Environmental, social, economic and legal concerns on the use of Emerging Technologies. Email us your unique piece to be posted
Read more

Get to know Dr Atheer Awad

Image
  Atheer is the APS Emerging Technologies Focus Group’s Post-doc representative. Atheer received her Bachelor’s degree in Pharmacy from Applied Science University in Jordan. She then pursued an MSc in Pharmaceutics at UCL School of Pharmacy, University College of London, where her research was aimed at exploring the potential of 3D printing for the formulation of abuse-deterrent and alcohol-resistant formulations. Earlier this year, she completed a PhD in Pharmaceutics at the same institution where her research was focused on fabrication of novel, bespoke pharmaceutical dosage forms using 3D printing.  Currently, Atheer is working as a Research Fellow at UCL School of Pharmacy as part of the Interreg 2 Seas Mers Zeeën project for site-specific drug delivery, looking into using 3D printing to improve colonic drug delivery.  She is one of youngest and leading researchers on the 3D printing of pharmaceuticals. In the past three years, she has published over 20 papers and book c
Read more

Get To Know Prof Clive Roberts

Image
  A career trying to help 'Emerging Technologies' be accepted   Whilst I still feel as excited as ever by the potential of the latest technologies and ideas to move research forward, I can reflect on a long career where I have seen many technologies emerge, some to blossom, some to disappear and then perhaps come back again.     For me personally I was so lucky to have had a PhD in Physics at Imperial College in the late 80's building and using the revolutionary Scanning Tunelling Microscope invented in 1981 at IBM to visualise and manipulate atoms and molecules. This tool changed the way we thought about ultra-resolution microscopy and provided a huge impetus for other technologies such as electron microscopy to improve. For me this led to my first research post in the School of Pharmacy, Nottingham University to apply STMs and the sister technique Atomic Force Microscopy in biomolecular and pharmaceutical analysis. Working in a multidisciplinary area such as Pharm
Read more